Heart Attack Risk 40% Higher in Men Taking Testosterone for the First Time, Study Finds
There is likely truth to allegations made in testosterone lawsuits that certain medications designed to raise levels of the male hormone may increase the risk for heart attacks and other cardiovascular problems, a recent study finds.
Among other things, research published in the medical journal Pharmacotherapy on January 13th reveals that men taking medications like AndroGel, Testim, Axiron and others for the first time are 40 percent more likely to have a heart attack than those who didn’t. The results, which were obtained by researchers from the University of British Columbia, follow an evaluation of data on nearly 1 million men between the ages of 45 and 80 who were taking them for the first time. These individuals were 41 percent more likely to have a myocardial infraction (MI) or heart attack, the study found.
The University of British Columbia researchers noted that more evidence was needed to confirm the association between current testosterone drug users and the risk for heart problems, as their research solely looked at first-time users. They maintained, however, that a “statistically significant association was observed between first-time TRT exposure and MI, although the absolute risk was low.”
Testosterone Study Speaks to Allegations in AndroGel Lawsuits
The findings of this study are noteworthy, given the mounting litigation surrounding prescription therapy testosterone treatments, and the U.S. Food and Drug Administration (FDA)’s stance over the past year that not enough research has proven their potential to cause cardiovascular problems. On January 31, 2014, the agency issued its first public health alert about the medications, in which they vowed to review their safety after research published in JAMA: Internal Medicine found an increased risk of heart attacks and other problems in younger men with a history of heart disease, and all men older than 65.
Meanwhile, testosterone lawsuits filed against the makers of AndroGel and other products are continuing to rise. A Case List updated on the Court’s website reflects the filing of 620 claims in a federal multidistrict litigation now underway in the U.S. District Court, Northern District of Illinois that similarly accuse their manufacturers of failing to warn about side effects that may be serious. Plaintiffs in these cases say testosterone medications were frequently prescribed off-label to treat “Low T” a condition categorized by low libido, sexual dysfunction, fatigue and other symptoms commonly associated with aging.
Consider a Testosterone Lawsuit
Call a testosterone attorney at our Firm to learn more about the mounting litigation involving these medications at (877) 779-1414.